Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability.
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (1) , 7-15
- https://doi.org/10.1023/a:1018828207920
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The effect of conformation on the membrane permeation of coumarinic acid‐ and phenylpropionic acid‐based cyclic prodrugs of opioid peptidesChemical Biology & Drug Design, 1999
- Synthesis and evaluation of the physicochemical properties of esterase‐sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkersChemical Biology & Drug Design, 1999
- The barrier function of CYP3A4 and P-glycoprotein in the small bowelAdvanced Drug Delivery Reviews, 1997
- Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategiesAdvanced Drug Delivery Reviews, 1997
- Effects of the Ester Moiety on Stereoselective Hydrolysis of Several Propranolol Prodrugs in Rat Tissues.Biological & Pharmaceutical Bulletin, 1995
- Opioid peptide interactions with lipid bilayer membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Recent developments in the design of receptor specific opioid peptidesMedicinal Research Reviews, 1989
- Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeabilityGastroenterology, 1989
- Carboxypeptidase A. Differences in the mechanisms of ester and peptide hydrolysisBiochemistry, 1974
- Serum esterases. 1. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determinationBiochemical Journal, 1953